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The Mad1/Mad2 Complex as a Template for Mad2
Activation in the Spindle Assembly Checkpoint
The SAC monitors this process and delays anaphase
until all chromosomes have attained bipolar attachment
[1, 2]. Spindlemicrotubules attach on kinetochores, pro-
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separase, which triggers anaphase by cleaving the com-
plex linking the sister chromatids, named Cohesin [4,
5]. The sequestration of Cdc20 requires Mad2 andSummary
BubR1 [1, 6]. Mad2 is a200 residue protein containing
a Horma domain [7]. BubR1 consist of an N-terminalBackground: The spindle assembly checkpoint (SAC)
domain containing Bub3 and Cdc20 binding sites and aimparts fidelity to chromosome segregation by delaying
C-terminal kinase domain (missing in the budding yeastanaphase until all sister chromatid pairs have become
ortholog, Mad3) [1, 6]. Both Mad2 and BubR1 bindbipolarly attached. Mad2 is a component of the SAC
Cdc20 tightly, and their effects are synergic [8–13]. Con-effector complex that sequesters Cdc20 to halt ana-
sistently, Mad2, BubR1 (or Mad3), Bub3, and Cdc20phase. In prometaphase, Mad2 is recruited to kineto-
enter a single complex known as mitotic checkpointchores with the help of Mad1, and it is activated to bind
complex (MCC) [11, 14–16].Cdc20. These events are linked to the existence of two
Unattached kinetochores establish and maintain thedistinct conformers of Mad2: a closed conformer bound
SAC, and all SAC proteins show kinetochore localizationto its kinetochore receptor Mad1 or its target in the
in prometaphase [1, 3, 17]. Fluorescence recovery aftercheckpoint Cdc20 and an open conformer unbound to
photobleaching (FRAP) revealed stable kinetochore res-these ligands.
idents, including Bub1, Mad1, and a fraction of Mad2,Results: We investigated the mechanism of Mad2 re-
and proteins with fast turnover at kinetochores, includ-cruitment to the kinetochore during checkpoint activa-
ingMad2, BubR1, Bub3, andCdc20 [18–21]. These stud-tion and subsequent transfer to Cdc20. We report that
ies envision a stable catalytic platformat the kinetochorea closed conformer of Mad2 constitutively bound to
that senses lack of microtubule attachment and acti-Mad1, rather than Mad1 itself, is the kinetochore recep-
vates Mad2 and BubR1 to form the MCC with Cdc20tor for cytosolic open Mad2 and show that the interac-
[1, 3, 6]. The exact composition of theMCCand the ordertion of open and closed Mad2 conformers is essential
of events subtending to its formation remain unclearto sustain the SAC.
(reviewed in [1, 6]). Mad2/Cdc20 and BubR1/Bub3/Conclusions: We propose that closed Mad2 bound to
Cdc20 subcomplexes may form in subsequent or paral-Mad1 represents a template for the conversion of open
lel steps with distinct dependencies. Here, we concen-Mad2 into closed Mad2 bound to Cdc20. This simple
trate on the essential role of Mad1 in promoting bindingmodel, which we have named the “Mad2 template”
of Mad2 to Cdc20, ignoring BubR1/Bub3, which is dis-model, predicts a mechanism for cytosolic propagation
pensable for this interaction [15, 22–25].of the spindle checkpoint signal away from kineto-
Mad1 is a 718 residue, predominantly coiled-coil pro-chores.
tein whose N-terminal domain supports Mad2-indepen-
dent binding to kinetochores in prometaphase [24, 26,Introduction
27]. The Mad1/Mad2 core complex is a tetrameric 2:2
assembly (Supplemental Figure S1) [28, 29]. Mad2 is
Before being divided into equal complements, sister
recruited to the kinetochore thanks to its interactionwith
chromatids attach to microtubules originating from op-
Mad1, and both proteins disappear from kinetochores
posite poles of the mitotic spindle (bipolar attachment).
upon microtubule attachment [12, 24, 26, 27, 30]. Be-
cause Mad1 and Mad2 are respectively stable and cy-
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φ is aliphatic, and X is any residue) that bind Mad2 in radius of the complex) demonstrates that Cdc20111–138
bindsMad2 and that pure C-Mad2 created by Cdc20111–138the same pocket [22, 29]. Second, Mad2 adopts two
conformations, openMad2 (O-Mad2, also known as N1- does not form Mad2 dimers, as shown previously
[22, 28].Mad2) and closedMad2 (C-Mad2, or N2-Mad2), differing
for a structural change in the “safety belt,” the 50 residue Next, we asked if Cdc20111–138 caused the release of
Mad2wt from Mad1/Mad2. The isolated Mad1485–718/C-terminal segment of Mad2 (Supplemental Figure S1)
[22, 29, 31, 32]. Mad2 adopts the closed conformation Mad2wt core complex eluted as a single peak with an
apparent molecular weight (MW) of 180 kDa (Figure 1D).when bound to Cdc20 or Mad1 and the open conforma-
tion when unbound to these ligands [22, 29, 31–33]. The elongated shape ofMad1/Mad2 likely explains devi-
ation from the expected MW (110 kDa) because theBecause a large energy barrier separates the O- and
C-Mad2 conformers [29, 32], the conformational transi- 2:2 stoichiometry is known from structural analysis [29]
and analytical ultracentrifugation (not shown). Whention may be rate limiting for the ability of Mad2 to bind
Cdc20 and ultimately for SAC activation. Thus, it is es- Mad1/Mad2 (20 M, tetramer concentration) was incu-
bated with a 10-fold excess of Cdc20111–138 and analyzedsential to understand the role of Mad1 in this transition.
We investigated how Mad1 recruits Mad2 from the by SEC (Figure 1E), we did not observe significant shifts
in the VE ofMad1/Mad2 nor the release ofMad2 orMad2/cytosol to the kinetochore and discovered that C-Mad2
stably bound to Mad1, rather than Mad1, constitutes Cdc20, as already reported [28, 29]. Thus, it cannot
be assumed that Mad2 dissociates from Mad1 to bindthe kinetochore receptor of O-Mad2. After being re-
cruited, O-Mad2 is converted into C-Mad2 bound to Cdc20. Despite similar Mad2 binding affinities of the
Mad1 and Cdc20 motifs (Supplemental Table S1 andCdc20. Although we do not provide direct insight into
how Mad1 bound C-Mad2 favors the conversion of [29]), Mad1/Mad2 is strongly stabilized by tetrameriza-
tion, explaining why Cdc20 does not remove Mad2 fromO-Mad2 into Cdc20 bound C-Mad2, we show that the
interaction between Mad1 bound C-Mad2 and O-Mad2 Mad1/Mad2 [28, 29].
In the “Mad2 exchange” model Mad1 and Cdc20 bindis essential to maintain the SAC. In our interpretation,
Mad1/Mad2 is a template for the formation of a structur- the sameMad2 pocket. Even if under appropriate condi-
tions Mad1/Mad2 dissociated to release Mad2 forally equivalent Cdc20/Mad2 copy that amplifies the SAC
signal away from kinetochores. Cdc20, Mad1 should be viewed as a competitive inhibi-
tor of Mad2/Cdc20 rather than a catalyst as proposed
[32]. To show this, we studied how the Mad2 binding
Results segment of Mad1 (Mad1527–555) influenced Mad2 binding
to Cdc20. If Mad1 catalyzed this interaction, on a time
Testing the “Mad2 Exchange” Model course, one should observe at least equal but possibly
In the recently proposed “Mad2 exchange” model [32], larger amounts of Cdc20 boundMad2 in the presence of
Mad1 lowers the energy barrier for the transition of Mad1 than in its absence. In the presence of increasing
O-Mad2 into C-Mad2 by recruiting O-Mad2 to kineto- amounts of Mad1527–554 peptide, Mad2 (3 M) was incu-
chores, changing its conformation to C-Mad2 and re- bated with GST-Cdc20111–138 (1.4 M) preabsorbed onto
leasing it as C-Mad2 for Cdc20 binding (Figure 1A). We glutathione-Sepharose (GSH) beads. At different times,
decided to test the assumption of this model that Mad1/ the beads were collected, washed, and the amount of
Mad2 functions as a source of Mad2 in the presence of bound Mad2 was evaluated (Figure 1F). In all experi-
Cdc20. In preliminary control experiments, we studied ments, we observed inhibition ofMad2 binding to Cdc20
the interaction of Mad2wt with Cdc20 in the absence of that increased with the concentration of Mad1527–554. This
Mad1. Although Mad2 binding to Cdc20 requires Mad1 confirms that direct exchange of Mad2 from Mad1 to
in vivo, it spontaneously occurs in vitro [22–24, 28]. We Cdc20 implicatesMad1 andCdc20 as competitors, con-
compared the elution profiles of Mad2wt from a Super- tradicting the proposition thatMad1 catalyses formation
dex-200 PC 3.2/30 size-exclusion chromatography ofMad2/Cdc20 [32]. Consistently, overexpression of the
(SEC) column with that of an incubation of Mad2 with Mad2 binding region of Mad1 abrogates the SAC likely
Cdc20 (Figures 1B and 1C). In agreement with previous because Mad2 engages in a complex with Mad1 that
reports, the elution volume (VE) of Mad2 (1.55 ml) was prevents it from binding Cdc20 [22, 24, 36]. Although
typical of an oligomer [22, 28, 31, 34]. As explained this does not prove the “Mad2 exchange” model wrong,
below, Mad2 forms oligomers thanks to the interaction it proves it inadequate to explain the requirements for
of its two conformers, O-Mad2 and C-Mad2. Bacterially fast activation of Mad2 for Cdc20 binding (the model is
expressed Mad2wt dimerizes because a fraction of further discussed in Supplemental Figures S2 and S3).
O-Mad2 spontaneously converts into empty C-Mad2
(i.e., devoid of Mad1 or Cdc20), which binds the residual
fraction of O-Mad2 [32, 33]. Mad1/Mad2 Binds Mad2 In Vitro
Knowing that Mad1 mediates kinetochore localizationMad2wt (40 M) was incubated for 1 hr with a 10-fold
excess of a synthetic peptide encompassing residues ofMad2 and thatMad1/Mad2 is stable, we hypothesized
that Mad1/Mad2, rather than Mad1, is the Mad2 recep-111–138 of Cdc20 (Cdc20111–138), a stronger Mad2 ligand
than full-length Cdc20 [9, 35], to generate Mad2/Cdc20. tor. To test this, we labeledMad2wt covalently with Alexa
Fluor 488 (abbreviated in Alexa) and compared the SECAfter SEC, a single Mad2wt peak was present whose VE
(1.65 ml, Figure 1C) indicated a 1:1 Mad2wt/Cdc20111–138 elution profiles of Alexa-modified Mad2 (40 M) before
or after adding stoichiometric amounts of Mad1/Mad2complex. The shift in VE relative to apo-Mad2wt (the Cdc20
peptide does not significantly contribute to the Stokes (20 M of divalent tetramer). Alexa-Mad2wt eluted as an
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Figure 1. Testing the “Mad2 Exchange” Model
(A) The “Mad2 exchange” model predicts that Mad1 binds O-Mad2 (defined N1-Mad2 in [29] and displayed as a red square), generating the
Mad1/Mad2 core complex (gray and yellow, respectively). This releases C-Mad2 (N2-Mad2 in [29] and displayed as a yellow circle) for Cdc20,
leaving a vacancy on Mad1 filled by O-Mad2.
(B) SEC elution profile of Mad2wt. All 50 l fractions spanning from 1.15 to 1.8 ml were separated by SDS-PAGE and stained with Coomassie.
(C) After incubating with Cdc20111–138, Mad2wt is turned into C-Mad2 and elutes as a 1:1 Mad2/Cdc20 complex. The Cdc20 peptide eluted after
the 2 ml mark.
(D) Elution profile of purified recombinant Mad1485–718/Mad2wt core complex.
(E) When incubated in vitro with Cdc20111–138, the core complex remains intact and does not release free Mad2/Cdc20.
(F) GST-Cdc20111–138 bound to GSH beads was incubated with Mad2wt with or without Mad1527–554. Beads were washed, and bound proteins
were identified by Coomassie staining after SDS-PAGE.
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oligomer (Figure 2B) (green trace reports Alexa ab- Mad2R133E-Q134A have complementary properties. Mad2C
fails to bind Mad1 and Cdc20 but retains the ability tosorbanceat 495nm).When incubated for 1 hrwithMad1/
Mad2, most Mad2wt entered a high MW complex coelut- bind C-Mad2 (Figure 2F and Table 1). Mad2R133E-Q134A
binds Mad1 and Cdc20, but its open conformer fails toing with Mad1/Mad2 (Figure 2C). Cdc20111–138 fails to dis-
sociate Mad1/Mad2 (Figure 1E). Conversely, when the bind C-Mad2 (Figure 2I, Table 1, Supplemental Figure
S5, and data not shown).complex of Alexa-Mad2wt with Mad1/Mad2 was treated
with a 10-fold excess of Cdc20111–134, most Alexa-Mad2wt
dissociated fromMad1/Mad2 and eluted with theMWof Mad1/Mad2 Is the Kinetochore Receptor of Mad2
Mad2/Cdc20111–134 (Figure 2D). Thus, Alexa-Mad2wt binds We asked if our results in vitro correlated with the ability
Mad1/Mad2differently from the core subunits,which are of the same Alexa-Mad2 species to bind the endoge-
insensitive to Cdc20111–134 (Figure 1E). Because Alexa- nous Mad2 receptor at kinetochores. Early prometa-
Mad2wt bound to Cdc20 has the C-Mad2 conformation, phase PtK1 cells were microinjected with 1%–5% cell
this experiment suggests that C-Mad2 is unable to bind volume of Alexa-labeledMad2wt, Mad2C, Mad2R133E-Q134A,
Mad1/Mad2. or Mad2C-R133E-Q134A (typically at needle concentrations
To corroborate these conclusions, we turned to Mad2 of 3 M) and analyzed by live cell fluorescence micros-
mutants with selectively altered functions (Table 1 and copy. Imaging was started 20 min after injection and
Supplemental Figure S4). Mad2C is unable to bindMad1 continued for 30 min. Out of 28 cells injected with
or Cdc20 because a 10-residue C-terminal deletion Alexa-Mad2wt, 26 showed strong kinetochore localiza-
locks the safety belt in the O-Mad2 conformation (Sup- tion at unattached kinetochores of chromosomes that
plemental Figure S1) [29, 31]. We confirmed this with hadnot congressed to the spindle equator, aspreviously
many new experiments (Supplemental Figure S5 and described [18], and only two showed weak localization
Supplemental Table S1). In SEC experiments, Alexa- (Figure 3A).
Mad2C eluted as a monomer (Figure 2E), showing that As Alexa-Mad2wt, also Alexa-Mad2C displayed kinet-
pure O-Mad2, like pure C-Mad2, does not form dimers. ochore localization at unattached kinetochores in 29 out
Like Alexa-Mad2wt, Alexa-Mad2C entered a stoichio- of 31 injected cells (Figure 3B). The Alexa-Mad2R133E-Q134A
metric complex with Mad1/Mad2 (Figure 2F). As ex- double mutant, on the other hand, failed to localize to
pected, however, Cdc20111–138 did not dissociate Mad2C the kinetochore in 22 of 23 injected prometaphase Ptk1
fromMad1/Mad2 (Figure 2G). BecauseMad2C is unable cells with only one dimly positive cell (Figure 3C) in
to form a core complex with Mad1 and Mad1 contains agreement with its inability to interact with the Mad1/
a single Mad2 binding site [22, 28, 29] (R. Hagan et al., Mad2 complex in vitro. To show that Mad2C uses the
submitted), we conclude thatMad1 binding is not required interface containing Arg133 and Gln134 to localize to
to recruit Mad2 onto the Mad1/C-Mad2 complex and kinetochores, we injected Alexa-labeled Mad2R133E-Q134A-C
that the recruited subunits are noncore (“external”). Fur- triplemutant in PtK1 cells. As expected,Mad2R133E-Q134A-C
thermore, the results confirm that “external” Mad2 is re- was unable to localize to the kinetochore in all 17 in-
cruitedonto theMad1/Mad2asO-Mad2, theconformation jected cells (Figure 3D), confirming that O-Mad2 (elicited
of Mad2C. by the C deletion) requires Arg133 and Gln134 to bind
its endogenous kinetochore receptor. The coincidence
of results with Mad2wt, Mad2C, Mad2R133E-Q134A, andMad2R133E-Q134A Fails to Bind Mad1/Mad2
Mad2R133E-Q134A-C in vitro and in living demonstrates thatIn summary, O-Mad2 binds (1) C-Mad2 in the Mad1/
the Mad1/Mad2 core complex, rather than Mad1, is theMad2 complex, (2) C-Mad2 generated with the Mad2
kinetochore receptor for Mad2. Our results confirm thatbinding motifs of Mad1 or Cdc20 (Supplemental Table
Mad2 is recruited to kinetochores as O-Mad2. Further-S1, Supplemental Figure S5, and data not shown), and
more, lack of kinetochore recruitment of an excellent(3) C-Mad2 spontaneously forming in bacterial prepara-
Mad1 ligand such as Mad2R133E-Q134A suggests that theretions of Mad2, causing its oligomerization [33]. Muta-
are no Mad2 vacancies on kinetochore Mad1 and thattions impairing the O-Mad2/C-Mad2 binding interface
Mad1/Mad2 is stable during checkpoint activation.should prevent Mad2 oligomerization. If such mutations
did not affect the potential of Mad2 to convert from O-
to C-Mad2, the ability to bind Mad1 and Cdc20 would Functional Analysis of Mad2C
Mad2C has a dominant-negative (DN) effect on the SACbe retained. Mad2R133A is a monomeric mutant that binds
tightly toMad1 and Cdc20 andwhose bacterial prepara- [12, 32, 36, 37]. As shown in Figure 4A, this effect can
be explained by the binding of Mad2C to Mad1/Mad2,tions contain both O-Mad2 and C-Mad2 [28, 29, 32].
Confirming our expectation, Alexa-Mad2R133A bound which creates an unproductive complex antagonizing
the transfer of endogenous O-Mad2 to Cdc20. Consis-poorly to theMad1/Mad2 complex [33]. To obtain amore
penetrant phenotype, we created the double mutant tent with this idea, Cdc20111–138 releases Mad2wt pre-
loaded onto the Mad1/Mad2 core complex (Figure 2D),Mad2R133E-Q134A (the Mad2R133A-Q134A mutant was insoluble).
Binding of Alexa-Mad2R133E-Q134A to Mad1/Mad2 was im- but notMad2C (Figure 2G). For confirmation of theprevi-
ous observations, HeLa cells were transfected withpaired (Figures 2H–2I). In solution and solid phase,
Mad2R133E-Q134A bound Mad1 and Cdc20 as effectively pCMV vectors expressing myc-tagged Mad2wt or
Mad2C to test the effects of their overexpression onas Mad2wt (Supplemental Table S1 and Supplemental
Figure S5). R133 and Q134 are invariant in all Mad2 the SAC (Figure 4B). 28–30 hr after transfection, half of
the culture was incubated with nocodazole to acti-orthologs [7], indicating that the binding function they
mediate is conserved in evolution. Mad2C and vate the SAC. 18 hr later, the cells were harvested and
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Figure 2. The Mad1/Mad2 Core Complex Binds O-Mad2
SDS-PAGE and Coomassie staining of the content of thirteen 50 l fractions eluting between 1.15 and 1.8 ml. Traces recorded at 280 nm
and 495 nm are black and green, respectively. A green bulb on Mad2 squares and circles indicates Alexa modification. (A) Elution profile of
the Mad1485–718/Mad2wt core complex, already shown in Figure 1B. (B) Profile of Alexa-Mad2wt. (C) SEC profile of Alexa-Mad2wt mixed with
stoichiometric amounts of Mad1485–718/Mad2wt core. Mad2wt is made of O-Mad2/C-Mad2 dimers, but only O-Mad2wt binds Mad1/Mad2. C-Mad2
and O-Mad2 interconvert rather rapidly. During a 1 hr incubation, most C-Mad2 is converted into O-Mad2, which then binds Mad1/Mad2,
explaining why the majority of Mad2wt is incorporated onto the Mad1/Mad2 complex. (D) As in (C), after addition of Cdc20111–138. The majority
of Alexa-Mad2wt is released from theMad1/Mad2 core in complexwithCdc20111–138. (E) Elution profile of Alexa-Mad2C. (F) Profile of stoichiometric
amounts of Alexa-Mad2C mixed with Mad1485–718/Mad2wt core. (G) Addition of Cdc20111–138 to Alexa-Mad2C bound to Mad1/Mad2 core complex.
Alexa-Mad2C does not dissociate in the presence of Cdc20111–138. (H) Elution profile of Alexa-Mad2R133E-Q134A. (I) Profile of Alexa-Mad2R133E-Q134A
incubated stoichiometrically with the Mad1/Mad2 core complex.
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Table 1. Properties of Mad2 and Mad2 Mutants
Binding Most Relevant
Conformation Mad1 or Cdc20 to Core References for
Mad2 Allele Mutation Effect Allowed Binding Complex Mutant
Mad2wt None Not applicable O-Mad2 Yes Yes
C-Mad2
Mad2C 10 residue Prevents conversion of O-Mad2 No Yes [28, 31, 32, 34,
C-terminal C-terminal tail into 36]
deletion closed position.
Mad2R133A Arg133 to Ala Prevents interaction of open O-Mad2 Yes Weak [28, 32, 40]





Mad2R133E-Q134A Arg133 to Glu Prevents interaction of open O-Mad2 Yes No This study




Mad2R133E-Q134A-C Arg133 to Glu Prevents interaction of open O-Mad2 No No This study
Gln134 to Ala 10 form with closed form
residue C-terminal and conversion of
deletion C-terminal tail into
closed position.
mitotic cells identified by flow cytometry for containing As it was an essential precondition for this experiment,
we tested the ability of the RNAi-insensitive alleles ofreplicated (4N) DNAand phosphorylated histoneH3 (H3-
P, a mitotic marker, Figure 4C). In the absence of noco- Mad2 to bind Mad1. HA-Mad2wt, HA-Mad2R133A, and HA-
Mad2R133E-Q134A, but not Mad2C, bound Mad1 after deple-dazole, overexpression of Mad2wt caused strong accu-
mulation of mitotic cells (Figure 4C, left), indicating that tion of endogenous Mad2 (Figure 5C).
Being expressed at relatively low levels, none of theMad2wt overexpression activates the SAC in HeLa cells.
Cells overexpressing Mad2C did not arrest in mitosis Mad2 alleles caused cell cycle arrest in the absence of
nocodazole (Figure 5D, left). In the presence of nocoda-in the absence of nocodazole, indicating that high levels
of this mutant are unable to trigger the SAC. In the zole, control cells depleted of Mad2 failed to arrest in
mitosis, showing that loss of Mad2 abrogates the SACpresence of nocodazole, HeLa cells transfected with an
empty pCMV vector or overexpressing Mad2wt arrested (Figure 5D, right, yellow bars). Complementation with
RNAi-insensitiveMad2wt reestablished a significant levelin mitosis, whereas Mad2C-expressing cells failed to
arrest, indicating that they are checkpoint defective (Fig- of mitotic arrest (red bars). As for analogous comple-
mentation experiments with BubR1 [39], we did not ob-ure 4C, right). Overexpression of Mad2R133A-C did not
perturb cell cycle progression in the absence of nocoda- serve full recovery of checkpoint competence in cells
expressing the RNAi-insensitive Mad2wt allele. A possi-zole and did not impair the SAC in nocodazole (Figure
4C). Because Mad2C differs from Mad2R133A-C only for ble explanation is that the expression levels of HA-Mad2
complementing endogenous Mad2 are not completelythe ability to bind Mad1/Mad2, we conclude that the DN
effect of Mad2C on the SAC requires C-Mad2 binding. stable, peaking at 40 hr after transfection and rapidly
decreasing thereafter (not shown).
Mad2R133A andMad2R133E-Q134Awere completely impairedFunctional Analysis of Mad2R133A and Mad2R133E-Q134A
If the interactionbetweenO-Mad2andMad1/Mad2were in complementing loss of Mad2 in nocodazole (Figure
5D, blue and violet bars). These alleles caused evenessential for the SAC, physiological concentrations of
mutants impaired in this interaction should be unable lower counts of mitotic cells than in the absence of
rescue constructs, suggesting an exacerbation of theto complement loss of Mad2wt (Figure 5A). To test this,
we asked whether physiological concentrations of checkpoint incompetence caused by loss of endoge-
nous Mad2. Despite the imperfect levels of recoveryMad2R133A and Mad2R133E-Q134A sustained the SAC in the
absence of endogenous Mad2. For this, we knocked obtained with Mad2wt, these results confirm that the
binding interface between O-Mad2 and C-Mad2 is es-down the expression of Mad2 in HeLa cells by RNA
interference (RNAi) and complemented its expression sential to maintain the SAC at physiological protein con-
centrations. Of note, pCMV-driven overexpression ofwith RNAi-insensitive, HA-tagged Mad2wt, Mad2R133A,
and Mad2R133E-Q134A alleles (Figure 5). Expression of en- Mad2R133A effectively arrested cells inmitosis to an extent
similar to that obtained with Mad2wt (not shown). Highdogenous Mad2 had substantially decreased after two
rounds of transfection of a pSuper vector expressing a levels of Mad2 may drive formation of sufficient Mad2/
Cdc20 by mass action, rendering the interaction ofshort hairpin targeting Mad2 [38]. In the meantime, the
expression of RNAi insensitive alleles of Mad2 and its O-Mad2 with C-Mad2 dispensable. This interaction,
however, is absolutely required at low Mad2 concentra-mutants from a pBabe vector cotransfectedwith pSuper
had reached near physiological conditions (Figure 5B). tions. Consistent with this, when moderately overex-
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Figure 3. Localization of Wild-Type and Mu-
tant Mad2 at the Kinetochore
PtK1 cells injected with Alexa-Mad2. For
each panel, the fluorescence (left) and the
phase contrast (right) images are shown. Im-
ages were acquired by taking a 13 plane/0.5
m-step Z series through the sample. The
images represent through focus projections
of planes containing kinetochores. (A) Kineto-
chore localization of Mad2wt with chromo-
somes that had not congressed to the spindle
equator (arrow). (B) Positive staining at unat-
tached kinetochores of cell injected with
Alexa-Mad2C. (C) Alexa-Mad2R133E-Q134A did
not localize to the kinetochore. (D) Alexa-
Mad2C-R133E-Q134A also failed to localize at the
kinetochore.
pressed in Xenopus blastomeres, only Mad2wt, but not 33]. It is possible that the O-Mad2 conformation is ac-
tivelymaintained in the cytoplasm to revert spontaneousMad2R133, promotes cell cycle arrest [40].
formation of ligand-free C-Mad2. In HeLa cells, Mad2
exists predominantly as O-Mad2, but bacterially ex-Discussion
pressed Mad2 populates both conformations in the
absence ofMad1 orCdc20 [32, 33]. Spontaneous forma-Here, we propose a new model to describe the roles of
tion of empty C-Mad2 in vitro is not necessarily signifi-Mad1 and Mad2 in the SAC, which we have named the
cant and not surprising when considering that the safety“Mad2 template” model (Figure 6). This model can be
belt is designed to convert reversibly fromO- to C-Mad2broken down as follows: (1) two distinct conformers of
and that empty C-Mad2 is stabilized by O-Mad2 in theMad2 exist: O-Mad2, which predominates in the cytosol
Mad2wt dimers.and accounts for the majority of Mad2, and C-Mad2,
Mad2 is recruited to kinetochores as O-Mad2 by thethe conformation Mad2 adopts when bound to Mad1 or
Mad1/C-Mad2 complex, and O-Mad2 and Mad1 boundCdc20; (2) Mad2 is recruited to kinetochores asO-Mad2,
C-Mad2 are distinct and nonexchanging (points 2–4). Inwith the exception of that contained in the Mad1/Mad2
this perspective, Mad1 and Cdc20 do not compete forcomplex; (3) the O-Mad2 receptor at the kinetochore is
Mad2 binding despite their relatedMad2 binding motifs.Mad1/Mad2—Mad1 promotes kinetochore localization
The existence of Mad1-free and Mad1 bound pools ofofMad1/Mad2, andC-Mad2 contains the critical surface
Mad2, corresponding to70%and30%of totalMad2,of the O-Mad2 receptor; (4) O-Mad2 and Mad1 bound
respectively, is well established, but it was unclearC-Mad2 are distinct and nonexchanging within the time-
whether these pools exchanged Mad2 subunits at rel-frame of SAC activation; (5) the interaction with C-Mad2
evant rates [8, 9, 14, 15, 22, 24, 26, 32]. Several indica-facilitates binding of O-Mad2 to Cdc20; and (6) the
tions suggest that the two pools remain distinct: (1)Cdc20/C-Mad2 complex represents a structural copy
recombinant Mad1/Mad2 is stable and does not releaseof Mad1/C-Mad2 acting to promote further transforma-
Mad2 in the presence of Cdc20 in vitro (Figure 1); (2)tion of O-Mad2 into Cdc20 bound C-Mad2 away from
Mad2R133E-Q134A, which binds Mad1, but not C-Mad2, failskinetochores.
to be recruited to kinetochores, suggesting that thereThere is good evidence that C-Mad2 and O-Mad2 are
are no C-Mad2 vacancies to be filled (Figure 3)—givenstable conformations of Mad2 (point 1) [22, 28, 29, 31,
32]. O-Mad2 is the conformation of cytosolic Mad2 [32, the high turnover rate of Mad2 at the kinetochore [18,
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Figure 4. Functional Analysis of Mad2C in HeLa Cells
(A) Model for dominant-negative effect of Mad2C. After binding Mad1/Mad2, Mad2C prevents kinetochore recruitment of O-Mad2wt and
formation of Mad2/Cdc20.
(B) Western blotting with an anti-Mad2 Ab of lysates of HeLa cells transfected with empty pCMV (lane 1) or pCMV expressing myc-Mad2wt
(lane 2), myc-Mad2C (lane 3), and myc-Mad2R133A-C (lane 4). Like Mad2R133E-Q134A-C, this mutant does not bind the Mad1/Mad2 core [33].
(C) Left, 44–46 hr post transfection of the indicated constructs, HeLa cells were harvested, and DNA content and Ser10 phosphorylation of
Histone H3 (H3P, a mitotic marker) was analyzed for myc-positive cells by three-color flow cytometry. Right, 26–28 hr post transfection of
the indicated constructs, nocodazole was added to trigger the checkpoint. Cells were harvested after 18 hr and analyzed as above. Error
bars represent standard deviations.
20, 21], if C-Mad2 core subunits were exchanging, we interaction depends on Mad1 in living cells, appropriate
conditions recreating this dependency in vitro mustwould expect significant kinetochore recruitment of
Mad2R133E-Q134A; (3) an immobile pool of Mad2 at mitotic be identified. Furthermore, Cdc20 segments such as
Cdc20111–138 bind Mad2 more tightly than full-lengthkinetochores coexists with a high turnover mobile frac-
tion of equal intensity [20]. Most likely, visualization of Cdc20, and Cdc20 is also expected to undergo defined
rearrangements to bind Mad2 [9, 35, 41]. These eventsthis immobile fraction was made possible by longer
times of incorporation of fluorescent Mad2 into the may take place on a unique platform at the kinetochore,
whose exact composition needs now to be unveiled.Mad1/Mad2 core complex relative to other analyses [18,
21]. Given that Mad1 is immobile [20, 21], the nonrecov- Addressing the role of the O-Mad2/C-Mad2 interaction
directly with purified components is unlikely to yieldering fraction of Mad2 likely represents C-Mad2 in the
Mad1/Mad2 complex. insightful responses before more sophisticated in vitro
assays are developed.We did not address how the interaction of O-Mad2
with Mad1/C-Mad2 facilitates binding of Mad2 to Cdc20 We postulate that the SAC starts when Mad1/Mad2
and O-Mad2meet at the kinetochore near nuclear enve-(point 5). All genetic and biochemical evidence shows
that Mad2 binding to Cdc20 is Mad1 dependent [15, lope breakdown. This enhances the transformation of
O-Mad2 into Cdc20 bound C-Mad2 (Figure 6A). In the22–25]. Because the role of Mad1 is to localize C-Mad2
at kinetochores, we propose that Mad1 bound C-Mad2 absence of stimulatory kinetochore function, the rate of
formation of the MCC complex is insufficient to avoidis also required to form Mad2/Cdc20. Indeed, the inter-
action of O-Mad2 with C-Mad2 is essential to maintain anaphase prior to completion of kinetochore attach-
ment. In this model, kinetochores accelerate the forma-the checkpoint (Figures 5 and 6). The structural conver-
sion of O-Mad2 into C-Mad2 bound to Cdc20 involves tion of theMCC,whereas its rate of disassembly remains
relatively fast to allow rapid anaphase onset upon com-relatively large activation energies [22, 29, 32]. We sus-
pect that the O-Mad2/C-Mad2 interaction accelerates pletionof bipolar attachment. This implies faster dissoci-
ation of Cdc20/Mad2 relative to Mad1/Mad2. For rea-this conversion during SAC activation. A structural in-
vestigation of the O-Mad2/C-Mad2 complex is under- sons discussed above, this is reasonable but will need
to be reassessed with the MCC of which Cdc20/Mad2way and will hopefully shed light on how this conversion
takes place. We are also investigating if and how the is only a subcomplex.
Although we do not have a molecular description ofMad1/Mad2 core complex directly affects the kinetics
of Mad2 binding to Cdc20. Because the Mad2/Cdc20 this mechanism, our data indicate that C-Mad2 bound
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Figure 5. Functional Analysis of Mad2R133A and Mad2R133E-Q134A in HeLa Cells
(A) Mad2R133A and Mad2R133E-Q134A mutants are expected to be unable to sustain the SAC in the absence of Mad2wt. Both mutants bind Mad1
as tightly as Mad2wt. Because both mutants are impaired in O-Mad2/C-Mad2 binding, they cannot sustain the SAC.
(B) Mad2 expression in HeLa cells was silenced by RNAi (lane 1) with pSUPER-Mad2 [38]. Mad2wt (lane 2), Mad2R133A (lane 3), Mad2R133E-Q134A
(lane 4), and Mad2C (lane 5) alleles made insensitive to RNAi with silent point mutations were expressed as HA-tag fusions from a pBabe
vector cotransfected with pSUPER. HA-tagged Mad2 expressed from pBabe was detected with an anti-Mad2 antibody.
(C) HA-tagged Mad2 proteins enter a complex with Mad1, as shown by immunoprecipitation. Mad2C was the only allele that did not interact
with Mad1 in the absence of endogenous Mad2.
(D) Left, flow cytometry of exponentially growing HeLa cells transfected with the indicated vectors. Right, cell cycle profiles of cells harvested
18 hr after adding nocodazole. Error bars represent standard deviations.
toMad1 favors the transformation ofO-Mad2 intoC-Mad2 Mad1, C-Mad2/Cdc20 released in the cytoplasm might
cause further conversion of O-Mad2 into C-Mad2/Cdc20.bound to Cdc20. This is reminiscent of the template-
assisted conversion of prion proteins [42]. For sake of This speculation, which is contained in point 6 of the
model, suggests that signal amplification in the SAC isclarity, we are not proposing that Mad2 is a prion be-
cause differences with prions are heavier than similari- caused by the C-Mad2-generating activities of kineto-
chore C-Mad2/Mad1 core and cytoplasmic C-Mad2/ties in this comparison. For instance, the transformation
of Mad2 may be completely reversible and protein mis- Cdc20 (Figure 6).
The characterization of p31comet (previously known asfolding is unlikely to play a role in the regulation of Mad2.
Furthermore, prions instate an inheritable state,whereas CMT2) as aMad2 ligand required to exitmitosis provides
a strong indication in favor of this model [43]. Asthere is no evidence that Mad2 has such properties.
From a structural perspective, however, the parallel O-Mad2, also p31comet recognizes selectively C-Mad2 in
the Mad1/Mad2 and Cdc20/Mad2 complexes and failsholds as it emphasizes a mechanism of homodimeriza-
tion based on the selective interaction of different con- to bind O-Mad2 [44] (R. Hagan et al., submitted). The
“Mad2 template” model suggests that p31comet hampersformers of the same protein, ultimately resulting in the
conversion of one into the other. The parallel is also the transformationofO-Mad2 intoC-Mad2bycompeting
with O-Mad2 for binding to C-Mad2/Mad1 and C-Mad2/conceptually useful as it suggests a mechanism for sig-
nal amplification in the SAC (point 6). Mad1 and Cdc20 Cdc20 (Figure 6B), a prediction that we are currently
testing.share a similar Mad2 binding motif, and Mad2 adopts
the C-Mad2 conformation within both complexes [22,
29]. In this respect, the C-Mad2/Mad1 and C-Mad2/ Conclusions
We show that Mad1/Mad2 is the kinetochore receptorCdc20 complexes are structurally equivalent. Their rela-
tionship is one of template (C-Mad2/Mad1 core) and for Mad2. The interaction of distinct Mad2 conformers
is the core of the “Mad2 template” model and allowscopy (C-Mad2/Cdc20). As a functional copy of C-Mad2/
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sequence of human Mad2 separated from human 6His-Mad1485–718
by a ribosome binding site. We generated pET43-6His-Mad2,
pET43-6His-Mad2R133A/Q134A, and pET43-6His-Mad2C by ligation into
NdeI/EcoRI sites of pET43. The Mad2 coding sequence was ligated
into BamHI of pBabe-HA-puro to obtain pBabe-HA-Mad2. Mutants
were generated with QuikChange (Stratagene).
Expression, Purification, and Alexa Labeling of Proteins
Mad2/6His-Mad1485–718 was expressed in E.coli BL21-c41(DE3). Mad2
was expressed at limiting levels with respect to 6His-Mad1. A stoi-
chiometric core formsbecause excess 6His-Mad1unbound toMad2
is insoluble in E. coli. After affinity chromatography on Ni-NTA-
agarose (Qiagen), the protein was purified by ion exchange and SEC
on Superdex-200 in PBS. Mad2 proteins were expressed in E. coli
BL21(DE3) and purified as described [28]. Proteins were labeled
with Alexa-488 succimidyl ester dye (Molecular Probes, Inc.) as
described [18] with final dye-to-protein ratio of 2:1.
Microscopy
Culture of PtK1 cells, microinjection, digital imaging microscopy,
and image analysis were previously described [18]. Early prometa-
phase cells were microinjected with about 1%–5% cell volume of
Alexa-labeled Mad2 proteins at about 3 M needle concentration.
Cells were imaged on a Nikon TE300 inverted microscope equipped
with a Nikon 100/NA 1.4 Plan Apo phase objective and an Orca
II ER cooled-CCDcamera (Hamamatsu). Fluorescencewasdetected
by using 22 binned images with 250 msec exposures.
Analytical SEC
Analytical SEC was carried out on a SMART device (Amersham-
Pharmacia Biotech) with a Superdex-200 PC 3.2/30 column in PBS.
20 MMad2/6His-Mad1485–718 complex was incubated for 1h at 20C
with 40 MAlexa-Mad2 or Alexa-Mad2mutants. The reactions were
separated by SEC. Elution was carried out at 40 l/min.
Cell Culture and Transfection
HeLa cells were grown in Dulbecco’s modified Eagle medium
(DMEM, Euroclone) supplemented with 10% bovine calf serumFigure 6. A New Model for the Spindle Checkpoint
(Hyclone) and 2 mM L-glutamine. Growing HeLa cells were trans-(A) Encounter of O-Mad2 with C-Mad2 bound to Mad1 starts the
fected with either a standard calcium phosphate precipitation pro-SAC. The Mad1/Mad2 core complex recruits O-Mad2 to kineto-
cedure or lipofectamine reagent (Gibco-BRL). Nocodazole (Sigma)chores, and O-Mad2 is converted into C-Mad2 bound to Cdc20.
was used at 100 ng/ml. PtK1 cells were grown as described [18].Mad2/Cdc20 is a structural copy of Mad1/Mad2 because Mad1 and
Cdc20 share a Mad2 binding motif and Mad2 adopts the same
AntibodiesC-Mad2 conformation in these complexes. The C-Mad2/Cdc20
Anti-Mad2 (clone AS55-A12) and anti-Mad1 (clone BB3-8) mono-complex dissociates from the Mad1/Mad2 core complex. In the
clonals were obtained by immunizing Balb/C mice with the Mad2/cytosol, Mad2/Cdc20 acts as a structural equivalent of Mad1/Mad2
Mad1485–718 complex and produced at the IFOM-IEO campus mono-to convert more O-Mad2 into Cdc20 bound C-Mad2. Signal amplifi-
clonal antibody facility; AC-40 anti-actin monoclonal was fromcation occurs because Mad2/Cdc20 converts O-Mad2 to Cdc20
Sigma; 16B12 anti-HA monoclonal and polyclonal anti-HA antibodybound C-Mad2. Dashed arrows represent hypothetical steps related
were from BABCO; 9E10 anti-c-Myc monoclonal was from Onco-to the amplification of the SAC signal by Mad2/Cdc20.
gene; rabbit polyclonal anti-phospho-histone-H3 was from Upstate(B) A “separator” protein between O-Mad2 and C-Mad2 inactivates
Biotechnology. Donkey anti-mouse or anti-rabbit IgG secondarythe SAC. p31comet binds C-Mad2 and prevents its interaction with
antibodies conjugated to either FITC or Cy5 were from JacksonO-Mad2. The encounter of O-Mad2 and C-Mad2 may require the
Laboratories, Inc.temporary inactivation of p31comet. The Mad1/Mad2 core complex
is removed from the kinetochore by a dynein-dependent mecha-
Immunoprecipitationsnism [45].
HeLa cells were harvested by trypsinization and lysed in 50 mM
Hepes (pH 7.5), 150 mMNaCl, 0.5%NP40, 1% glycerol, 5 mM EDTA,
10 mM Na3VO4, 50 mM NaF, 20 mM Na4-pyrophosphate, 100 ng/ml
understanding the behavior of Mad2 in the SAC. The leupeptine, 100 ng/ml Aprotinin, and 1 mM PMSF for 20 min on ice.
novelty of the model presented here is that it includes Cell lysates were centrifuged for 15 min at 13,000 rpm at 4C in an
Eppendorf microcentrifuge. Protein amounts were measured witha mechanism for SAC signal amplification away from
protein assay reagent (Bio-Rad Laboratories) as specified by thethe kinetochore. Attempts to validate this model and to
manufacturer, and equivalent amounts of total protein were usedunderstand the interaction of Mad2/Cdc20 with other
for immunoprecipitation. 0.4 mg of each cell lysate were incubated
components of the SAC, such as Bub1, BubR1, and with 2 g of rabbit polyclonal anti-HA antibody (BABCO) for 1 hr at
Bub3, are undergoing in our laboratories. 20C followed by incubation with protein A Sepharose beads for 2
hr. The beads were washed three times in lysis buffer, eluted in SDS
sample buffer, and analyzed by SDS-PAGE and Western blotting.Experimental Procedures
Plasmids RNAi and Overexpression
HeLa cells (50% confluence) were cotransfected with calcium phos-pGEX-Mad1523–550, pGEX-CDC20111–138, and pCMV-mycMad2 were
described [28]. pET43-Mad2/6His-Mad1485–718 contains the coding phate twice at 24 hr intervals with 8 g pSUPER-Mad2 [38] and 10
Current Biology
224
g of rescue constructs pBABE-HA-Mad2, pBABE-HA-Mad2R133A, 11. Millband, D.N., and Hardwick, K.G. (2002). Fission yeast Mad3p
is required for Mad2p to inhibit the anaphase-promoting com-or pBABE-HA-Mad2R133E-Q134A containing silent mutations GAA169 and
TCT170 in place of Mad2 codons GAG169 and TCG170. 20–24 hr after plex and localizes to kinetochores in a Bub1p-, Bub3p-, and
Mph1p-dependent manner. Mol. Cell. Biol. 22, 2728–2742.second transfection, cells were split 1:3 tomaintain log phase. 30–40
hr after second transfection, nocodazole was added (100 ng/ml). 12. Shannon, K.B., Canman, J.C., and Salmon, E.D. (2002). Mad2
and BubR1 function in a single checkpoint pathway that re-Cells were harvested 18–22 hr after adding nocodazole and treated
for FACS. Samples were also lysed and analyzed by Western blot- sponds to a loss of tension. Mol. Biol. Cell 13, 3706–3719.
13. Meraldi, P., Draviam, V.M., and Sorger, P.K. (2004). Timing andting. For overexpression, HeLa cells were grown to 70% confluence
and transfected with 10 g pCMV-mycMad2 (or Mad2 mutants) by checkpoints in the regulation of mitotic progression. Dev. Cell
7, 45–60.using lipofectamine, and after 16–18 hr, cells were split 1:3. 26–28
hr after transfection, nocodazole was added. Cells were harvested 14. Sudakin, V., Chan, G.K., and Yen, T.J. (2001). Checkpoint inhibi-
tion of the APC/C in HeLa cells is mediated by a complex of18 hr after nocodazole addition and treated for FACS analysis orWB.
BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154, 925–936.
15. Fraschini, R., Beretta, A., Sironi, L., Musacchio, A., Lucchini, G.,Flow Cytometry
and Piatti, S. (2001). Bub3 interaction with Mad2, Mad3 andCells were harvested by trypsinization and fixed with 1% formalde-
Cdc20 is mediated byWD40 repeats and does not require intacthyde and 75% ethanol. After fixation, cells were permeabilized with
kinetochores. EMBO J. 20, 6648–6659.0.1% Triton X-100 and stained with anti-phospho-histone-H3, anti-
16. Hardwick, K.G., Johnston, R.C., Smith, D.L., and Murray, A.W.myc, or anti-HA antibodies. For DNA content, cells were treated
(2000). MAD3 encodes a novel component of the spindle check-with 5 g/ml propidium iodide and 250 g/ml RNaseA. Data acquisi-
point which interacts with Bub3p, Cdc20p, and Mad2p. J. Celltion and analysis were performed by using a FACSCalibur flow cyto-
Biol. 148, 871–882.meter (Becton Dickinson) with CellQuest 3.3 software.
17. Gorbsky, G.J., Kallio, M., Daum, J.R., and Topper, L.M. (1999).
Protein dynamics at the kinetochore: cell cycle regulation ofSupplemental Data
the metaphase to anaphase transition. FASEB J. Suppl. 13,Supplemental Data include four figures and a table and can be
S231–S234.foundwith this article online at http://www.current-biology.com/cgi/
18. Howell, B.J., Hoffman, D.B., Fang,G.,Murray, A.W., andSalmon,content/full/15/3/214/DC1/.
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